SpectraBase Spectrum ID |
8JIsXnMyPvk |
Name |
Thiopentone 2ME |
Classification |
Pharmaceutical drug, hypnotic |
Copyright |
Copyright © 2024 DigiLab GmbH and Wiley-VCH GmbH. All Rights Reserved. |
DEA Citation |
21 CFR §1308.13 (c) (3) |
DEA Controlled Substance Form |
Any compound, mixture or preparation |
DEA Controlled Substance Name |
Barbituric acid derivatives |
DEA Controlled Substance Type |
Salts, isomers, derivatives and salts of isomers and derivatives |
DEA Controlled Substances Code Number |
2100 |
DEA Schedule |
Schedule III |
DEA Section |
Depressants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system |
Exact Mass |
270.140199128 u |
Formula |
C13H22N2O2S |
InChI |
InChI=1S/C13H22N2O2S/c1-6-8-9(3)13(7-2)10(16)14(4)12(18)15(5)11(13)17/h9H,6-8H2,1-5H3 |
InChIKey |
DZSBVSFFHQBTFT-UHFFFAOYSA-N |
Ionization Type |
Electron Ionization (EI) |
Molecular Weight |
270.391 g/mol |
Nominal Mass |
270 u |
Quality |
909 |
Retention Index |
2018 |
SMILES |
C1(C(N(C(N(C1=O)C)=S)C)=O)(C(CCC)C)CC |
SPLASH |
splash10-0udi-7970000000-993aa1494444d6126cd5 |
Source of Spectrum |
DigiLab GmbH (C) 2024 |
Synonyms |
5-ethyl-1,3-dimethyl-5-(pentan-2-yl)-2-thioxo-1,3-diazinane-4,6-dione |
Technique |
GC/MS |
Wiley ID |
DD2024_004029 |